Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.
J Clin Invest
; 130(7): 3865-3884, 2020 07 01.
Article
in En
| MEDLINE
| ID: mdl-32324593
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Microenvironment
/
Myeloid-Derived Suppressor Cells
/
Immunity, Cellular
/
Macrophages
/
Neoplasms, Experimental
Limits:
Animals
Language:
En
Journal:
J Clin Invest
Year:
2020
Document type:
Article
Country of publication:
Estados Unidos